Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

80.63
Delayed Data
As of 4:02pm ET
 -0.72 / -0.89%
Today’s Change
66.93
Today|||52-Week Range
83.58
+10.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Operating ActivitiesNet Income / Starting Line1.8B2.0B921.9M1.6B
 
 
 
 
 
Depreciation1.5B1.5B985.2M1.8B
 
 
 
 
 
Total Other Cash Flow93.4M-119.7M-782.6M12.9M
 
 
 
 
 
Funds From Operations3.4B3.4B1.1B3.4B
 
 
 
 
 
Funds From/For Other Operating Expenses282.6M116.0M-2.4B1.4B
 
 
 
 
 
Net Cash Flow - Operating Activities3.1B3.3B3.5B2.0B
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-775.3M-14.9M
 
 
 
Decrease In Investments0.0089.2M777.9M0.00
 
 
 
Capital Expenditures-452.2M-449.6M-579.0M-340.8M
 
 
 
 
 
Fixed Asset Disposal97.9M343.9M-799.6M349.8M
 
 
 
 
 
Net Assets From Acquisitions -18.5M-107.1M-232.1M-653.0M
 
 
 
 
 
Other Investing - Uses-484.4M482.5M-371.8M-46.6M
 
 
 
 
 
Other Investing - Sources4.5M-33.9M845.2M0.00
 
 
 
 
Net Cash Flow Investing-852.6M-764.5M-1.1B-1.1B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings-1.5B109.1M-2.2B7.2B
 
 
 
 
 
Long Term Debt Reduction0.00----0.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-98.5M-412.8M-415.0M-1.0B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-101.7M-42.7M29.3M-6.4B
 
 
 
 
 
Other Sources - Financing5.0M-5.0M220.5M0.00
 
 
 
 
Other Uses - Financing-28.4M9.0M-3.0M68.4M
 
 
 
 
 
Net Cash Flow - Financing-1.7B-360.4M-2.3B-384.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-45.2M962.9K-381.2M8.9M
 
 
 
 
 
 
Net Change In Cash618.3M2.1B203.2M550.9M